Faculty Profile

Michael Lowe, MD, MA

Michael Lowe, MD, MA

Associate Professor of Surgery, Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine

Director, Extramural Studies, General Surgery Residency, Department of Surgery, Emory University

Clinical Director, Morningside Center for Innovative and Affordable Medicine, Woodruff Health Sciences Center

Telephone: 404.778.3303

Email: michael.lowe@emory.edu

Certification: American Board of Surgery, Complex General Surgical Oncology

Year Joined Emory as a Faculty Member: 2016


Dr. Lowe received his MD and graduated cum laude from Georgetown University School of Medicine. He served as administrative chief resident during the final year of his general surgery residency at the Emory Department of Surgery. He joined the Emory faculty after completing a fellowship in complex general surgical oncology at Memorial Sloan Kettering Cancer Center. Dr. Lowe received several awards during his training years, including the Young Investigator Award of the American Society of Transplant Surgeons in 2011 and 2012.

His clinical practice and research interests focus on cutaneous malignancies, particularly melanoma and Merkel cell carcinoma, and he is known for building a cutaneous malignancy program at Emory Saint Joseph's Hospital. Watch Dr. Lowe discuss aspects of treating melanoma in these educational videos produced by the Winship Cancer Institute: treating a recurrence of melanoma, using surgery to treat melanoma, and the role of the sentinel lymph node in melanoma.

In 2018, Dr. Lowe received the Society of Surgical Oncology's (SSO) Young Investigator Award for his study, "Evaluation of FcyRIIB as a Novel T cell Inhibitor in Cutaneous Melanoma." The study is investigating new pathways to enhance the immune system's response to melanoma, defining the role of the Fc receptor FcyRIIB in promoting exhaustion in T cell responses to tumor growth, and examining the benefits of blocking FcyRIIB's ability to alter T cell responses.


View Dr. Lowe's publications in ResearchGate.


  • Emory University Hospital

  • Emory Saint Joseph's Hospital


  • MD, Georgetown University School of Medicine, Washington, DC, Class of 2007

  • MA, Liberal Studies, Georgetown University, Washington, DC, 2007

  • General Surgery Internship, Emory University School of Medicine, Atlanta, 2007-2008

  • General Surgery Residency, Emory University School of Medicine, Atlanta, 2008-2014

  • Postdoctoral Research Fellow, Robbins Fellow in Islet Transplantation, Emory Transplant Center, Emory University, Atlanta, 2010-2012

  • Complex General Surgical Oncology Fellowship, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, 2014-2016

Honors and Awards

  • Junior Resident Teaching Award, Emory Department of Surgery, 2019

  • Young Investigator Award, Society of Surgical Oncology, 2018

  • Young Investigator Award, American Society of Transplant Surgeons, 2011, 2012

  • Robbins Fellowship in Islet Transplantation, 2011

  • Best Basic Science Presentation, Emory Department of Surgery Research Symposium, 2011

  • J.D. Martin Surgical Resident Award, Emory Department of Surgery, 2010

  • Best Clinical Science Oral Presentation, Georgia Chapter, American College of Surgeons, 2009

  • Alpha Omega Alpha, 2006

Current Organizational Memberships

  • American College of Surgeons

  • American Society of Clinical Oncology

  • International Neoadjuvant Melanoma Consortium

  • Eastern Cooperative Oncology Group: Surgery Committee, Melanoma Commitee

  • Society of Surgical Oncology: Corporate Relations Committee

  • Society for Melanoma Research

  • Association for Academic Surgery

  • Southeastern Surgical Congress

Current Editorships and Editorial Boards

  • Editorial Board, Journal of Surgical Research

  • Editorial Board, Journal of Surgical Oncology

Clinical Interests

  • Melanoma

  • Merkel cell carcinoma

  • Cutaneous malignancies

Research Interests

  • The impact of surgery on the management of all stages of melanoma

  • Developing novel immune targets in collaboration with tumor immunologists

  • Evaluating the impact of neoadjuvant treatments on patients with resectable metastatic melanoma